Janus kinase inhibition and symptom control in myeloproliferative neoplasms

Curr Med Res Opin. 2018 May;34(5):935-937. doi: 10.1080/03007995.2018.1438999. Epub 2018 Mar 12.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Humans
  • Janus Kinases
  • Japan
  • Neoplasms*
  • Nitriles
  • Primary Myelofibrosis*
  • Pyrazoles
  • Pyrimidines
  • Quality of Life

Substances

  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib
  • Janus Kinases